Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

Ryerson University

$50,000.00

Assessment of COVID-19 Droplets in a Clinical Setting to Reduce the Risk to Health Care Providers_x000d_

EF 2020-21

Résumé
The COVID-19 pandemic continues to grow rapidly with over 85,000 confirmed cases in Canada. While efforts are being made to develop pharmaceutical SARS-CoV-2 (the virus that causes COVID-19) remedies, a COVID-19 vaccine still has a 12-18-month horizon according to the World Health Organization (WHO). This means that COVID-19 related hospitalizations will continue to stress our healthcare system. It is estimated that healthcare providers make up 1 in 7 known COVID-19 cases in Ontario. There is therefore an immediate need to protect our frontline health care professionals. Our partner organization, Unity Health Toronto, is in need of practical clinical guidelines to effectively use limited personal protective equipment sources. This requires an understanding of aerosol and droplet dispersion in a clinical setting. For example, critical information such as how clinical procedures affect COVID-19 carrying respiratory droplet release is not known. This project will develop a droplet-laden flow visualization experimental setup for optical measurements of aerosol and droplet size distribution and dynamics, and volume plume dispersion, in such a way that the platform can be used in both experimental laboratories and in clinical settings. Additionally, our team will develop a mechanical device that can simulate distribution and volume plume dispersion during human expiratory activities (e.g. talking, coughing, and sneezing), and during various clinical procedures, such as endotracheal intubation, or chest compressions. This work will aid Unity Health create practical clinical guidelines to combat COVID-19.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
554639-2020
Name nom
Karatas, Ahmet
Department département
Aerospace Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Assessment of COVID-19 Droplets in a Clinical Setting to Reduce the Risk to Health Care Providers_x000d_
Keyword
NSERC
Application summary
The COVID-19 pandemic continues to grow rapidly with over 85,000 confirmed cases in Canada. While efforts are being made to develop pharmaceutical SARS-CoV-2 (the virus that causes COVID-19) remedies, a COVID-19 vaccine still has a 12-18-month horizon according to the World Health Organization (WHO). This means that COVID-19 related hospitalizations will continue to stress our healthcare system. It is estimated that healthcare providers make up 1 in 7 known COVID-19 cases in Ontario. There is therefore an immediate need to protect our frontline health care professionals. Our partner organization, Unity Health Toronto, is in need of practical clinical guidelines to effectively use limited personal protective equipment sources. This requires an understanding of aerosol and droplet dispersion in a clinical setting. For example, critical information such as how clinical procedures affect COVID-19 carrying respiratory droplet release is not known. This project will develop a droplet-laden flow visualization experimental setup for optical measurements of aerosol and droplet size distribution and dynamics, and volume plume dispersion, in such a way that the platform can be used in both experimental laboratories and in clinical settings. Additionally, our team will develop a mechanical device that can simulate distribution and volume plume dispersion during human expiratory activities (e.g. talking, coughing, and sneezing), and during various clinical procedures, such as endotracheal intubation, or chest compressions. This work will aid Unity Health create practical clinical guidelines to combat COVID-19.